Corporació Sanitària Parc Taulí

Sabadell 08208

0 studies enrolling now · 2 studies all time

What they study most

Non-Small-Cell Lung Carcinoma, Small Cell Lung Cancer

Studies at this site

• Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung Cancer — Completed
• Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer — Stopped early